Диссертация (1150807), страница 20
Текст из файла (страница 20)
Przytycka T. M., Singh M., Slonim D. K. Toward the dynamic interactome: it's about time. //Brief Bioinform. 2010. Jan. Vol. 11, no. 1. P. 1529. URL:1093/bib/bbp057.http://dx.doi.org/10.166. Beauchemin C., Dixit N. M., Perelson A. S. Characterizing T cell movement within lymphnodes in the absence of antigen. // J Immunol.
2007. May. Vol. 178, no. 9. P. 55055512.167. Abbott L. H., Michor F. Mathematical models of targeted cancer therapy. // Br J Cancer. 2006.Nov.Vol. 95, no. 9.P. 11361141. URL:6603310.http://dx.doi.org/10.1038/sj.bjc.168. Kirschner D., Tsygvintsev A. On the global dynamics of a model for tumor immunotherapy. //Math Biosci Eng.
2009. Jul. Vol. 6, no. 3. P. 573583.169. Mallet D. G., De Pillis L. G. A cellular automata model of tumor-immune system interactions. // J Theor Biol.2006. Apr.Vol. 239, no. 3.P. 334350. URL://dx.doi.org/10.1016/j.jtbi.2005.08.002.http:170. Sarah M. Andrew, Christopher T.H. Baker, Gennady A. Bocharov. Rival approaches tomathematical modelling in immunology // Journal of Computational and Applied Mathematics.http://www.sciencedirect.com/science/article/pii/S037704270600392X.2007. Ò.
205, 2. Ñ. 669 686. URL:171. Juilee Thakar, Reka Albert. Boolean models of within-host immune interactions. // Curr OpinMicrobiol. 2010. Jun. Vol. 13, no. 3. P. 377381. URL:j.mib.2010.04.003.http://dx.doi.org/10.1016/172. Equation-based models of dynamic biological systems. / S. Daun, J. Rubin, Y. Vodovotzet al. // J Crit Care. 2008. Dec. Vol. 23, no. 4. P.
585594. URL:10.1016/j.jcrc.2008.02.003.http://dx.doi.org/173. Daun S., Clermont G. In Silico Modeling in Infectious Disease. // Drug Discov Today DisModels. 2007. Oct. Vol. 4, no. 3. P. 117122. URL:ddmod.2007.09.001.http://dx.doi.org/10.1016/j.174. Mathematical and computational challenges in population biology and ecosystems science. /S. A. Levin, B. Grenfell, A. Hastings et al. // Science. 1997.
Jan. Vol. 275, no. 5298. P. 334343.96175. Paul Anderson. Post-transcriptional control of cytokine production. // Nat Immunol.Apr. Vol. 9, no. 4. P. 353359. URL:2008.http://dx.doi.org/10.1038/ni1584.176. Ha Youn Lee, Alan S Perelson. Modeling T cell proliferation and death in vitro basedon labeling data:Biol.2008. Jan.generalizations of the Smith-Martin cell cycle model. // Bull MathVol. 70, no. 1.P. 2144. URL:s11538-007-9239-4.http://dx.doi.org/10.1007/177.
Disparate individual fates compose robust CD8+ T cell immunity. /Veit R Buchholz,Michael Flossdorf, Inge Hensel et al. // Science. 2013. May. Vol. 340, no. 6132. P. 630635.URL:http://dx.doi.org/10.1126/science.1235454.178. Rob J De Boer, Alan S Perelson.
Quantifying T lymphocyte turnover. // J Theor Biol. 2013.Jun. Vol. 327. P. 4587. URL:025.http://dx.doi.org/10.1016/j.jtbi.2012.12.179. Ðèçíè÷åíêî Ã. Þ., Ðóáèí À. Á. Áèîôèçè÷åñêàÿ äèíàìèêà ïðîäóêöèîííûõ ïðîöåññîâ. 2èçä. Ìîñêâà-Èæåâñê: Èíñòèòóò êîìïüþòåðíûõ èññëåäîâàíèé, 2004. Ñ. 464.180. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology andthe pathophysiology of systemic lupus erythematosus. /Agnes Doreau,Alexandre Belot,Jeremy Bastid et al. // Nat Immunol. 2009. Jul. Vol. 10, no. 7. P. 778785.
URL://dx.doi.org/10.1038/ni.1741.http:181. Kenneth M Murphy, Brigitta Stockinger. Effector T cell plasticity: flexibility in the face ofchanging circumstances. // Nat Immunol.2010. Aug.Vol. 11, no. 8.P. 674680. URL:http://dx.doi.org/10.1038/ni.1899.182. Simanta Pathak, Chandra Mohan. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. // Arthritis Res Ther. 2011.
Vol. 13, no. 5. P. 241.URL:http://dx.doi.org/10.1186/ar3465.183. Hedda Wardemann, Michel C Nussenzweig. B-cell self-tolerance in humans. // Adv Immunol.2007. Vol. 95. P. 83110. URL:95003-8.http://dx.doi.org/10.1016/S0065-2776(07)184. Cristina Arriens, Chandra Mohan. Systemic lupus erythematosus diagnostics in the `omics'era // Int. J. Clin. Rheumatol. 2013.
Ò. 8(6). Ñ. 671687.185. Sturfelt G., Johnson U., SjoholmA. G. Sequential studies of complement activation in systemiclupus erythematosus. // Scand J Rheumatol. 1985. Vol. 14, no. 2. P. 184196.186. Sandra G Guerra, Timothy J Vyse, Deborah S Cunninghame Graham. The genetics of lupus:a functional perspective. // Arthritis Res Ther. 2012. Vol. 14, no. 3.
P. 211. URL://dx.doi.org/10.1186/ar3844.97http:187. Jacob N., Stohl W. Cytokine disturbances in systemic lupus erythematosus. // Arthritis ResTher. 2011. Vol. 13, no. 4. P. 228. URL:http://dx.doi.org/10.1186/ar3349.188. Laurie S Davis, Jack Hutcheson, Chandra Mohan. The role of cytokines in the pathogenesisand treatment of systemic lupus erythematosus. // J Interferon Cytokine Res.Vol. 31, no. 10. P. 781789. URL:2011.
Oct.http://dx.doi.org/10.1089/jir.2011.0047.189. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. / Christophe Richez,Patrick Blanco,Vol. 78, no. 2. P. 124130. URL:09.005.Ian Rifkin et al. // Joint Bone Spine. 2011.
Mar.http://dx.doi.org/10.1016/j.jbspin.2010.190. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. /Sebas-tian Dolff, Wayel H Abdulahad, Johanna Westra et al. // Arthritis Res Ther. 2011. Vol.
13,no. 5. P. R157. URL:http://dx.doi.org/10.1186/ar3474.191. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. /Lai Wei, Arian Laurence, Kevin M Elias et al. // J Biol Chem. 2007. Nov. Vol. 282, no. 48.P. 3460534610. URL:http://dx.doi.org/10.1074/jbc.M705100200.192. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkeymodel.
/ R. P. Taylor, P. J. Ferguson, E. N. Martin et al. // Clin Immunol Immunopathol. 1997.Jan. Vol. 82, no. 1. P. 4959.193. Maria L Craig, Alexander J Bankovich, Ronald P Taylor. Visualization of the transfer reaction:tracking immune complexes from erythrocyte complement receptor 1 to macrophages. // ClinImmunol.
2002. Oct. Vol. 105, no. 1. P. 3647.194. Kavai M. Immune complex clearance by complement receptor type 1 in SLE. // AutoimmunRev. 2008. Dec. Vol. 8, no. 2. P. 160164. URL:autrev.2008.06.002.http://dx.doi.org/10.1016/j.195. Humoral suppression of erythropoiesis in systemic lupus erythematosus (SLE) and rheumatoidarthritis.
/ N. Dainiak, J. Hardin, V. Floyd et al. // Am J Med. 1980. Oct. Vol. 69, no. 4. P. 537544.196. Human autoantibody recognition of DNA. / S. M. Barbas, H. J. Ditzel, E. M. Salonen et al. //Proc Natl Acad Sci U S A. 1995. Mar. Vol. 92, no.
7. P. 25292533.197. Hughes Jones N. C. Functional affinity constants of the reaction between 125I-labelled C1qand C1q binders and their use in the measurement of plasma C1q concentrations. // Immunology. 1977. Feb. Vol. 32, no. 2. P. 191198.198. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. / L. B. Klickstein, S.
F. Barbashov, T. Liu et al. // Immunity. 1997. Sep. Vol. 7, no. 3. P. 345355.98199. Kohler P. F., MullerEberhard H. J. Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus. // J Clin Invest.
1972. Apr. Vol. 51,no. 4. P. 868875. URL:http://dx.doi.org/10.1172/JCI106881.200. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in twoethnic groups. / L. Xiang, J. R. Rundles, D. R. Hamilton et al. // J Immunol. 1999. Nov. Vol.163, no. 9. P.
49394945.201. Analysing cell-free plasma DNA and SLE disease activity. /Johanna Atamaniuk,Yu-Yang Hsiao, Monika Mustak et al. // Eur J Clin Invest. 2011. Jun. Vol. 41, no. 6. P. 579583.URL:http://dx.doi.org/10.1111/j.1365-2362.2010.02435.x.202. Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosed SLE patients after corticosteroid and chloroquine treatment. / A.-M. Cepika,Dragica Soldo Juresa,Jad-ranka Morovic Vergles et al. // Cell Immunol. 2012. Mar. Vol. 276, no. 1-2. P. 196203.
URL:http://dx.doi.org/10.1016/j.cellimm.2012.05.009.203. Mathematical model of a virus-neutralizing immunglobulin response. / G. A. Funk, A. D. Barbour, H. Hengartner et al. // J Theor Biol.1998. Nov.Vol. 195, no. 1.P. 4152. URL:http://dx.doi.org/10.1006/jtbi.1998.0779.204. Hamilton R. G. Human IgG subclass measurements in the clinical laboratory.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
